The United States is a hotbed of exciting cannabis stocks. States from one ocean to the other are passing laws legalizing production, distribution and most importantly, taxation of marijuana. Yet the federal government still officially bans marijuana in all its forms.

This dual standard is a major challenge for the multi-billion dollar industry. Federal law makes it almost impossible to profit from weed in the traditional sense. But public opinion and state laws have shifted significantly in the last couple decades.

Despite many setbacks, the cannabis community is making great strides towards full legalization. One area of the canna-economy seeing amazing growth is the stock market. Current reform allows for a growing number of exciting cannabis stocks to benefit by taking advantage of the relative tranquility around marijuana. So we put together a list of the 5 best opportunities for investors right now.

MPX Bioceutical: Undervalued

Perfect strategic execution and leveraging in the most competitive marijuana markets across the U.S. are two reasons MPX Bioceutical Corp. (MPX.CN) (MPFEF) is so attractive. They even set a new personal record in early April with a $4 million revenue announcement from their sales of cannabis and concentrates in Arizona alone.

As MPX brings on a fourth dispensary and a concentrate production facility later this year, their profits are projected to continue to rise. This leads to a bullish stance on MPX with the company’s favorable leverage in Maryland, Massachusetts and Nevada. Comparing them to Canadian companies with comparable numbers, MPX is currently undervalued with significant upside.

Plus Products: Exciting

Plus Products (Private) gets us really excited. Significant increases in edible manufacturing and distribution market share in California over the last year is attractive. Their product line has expanded from the initial infused gum to include gummies. Additionally, they secured new manufacturing facilities and equipment,

Read More Here...